Unknown

Dataset Information

0

Protective effect of milk fat globule-epidermal growth factor-factor VIII after renal ischemia-reperfusion injury in mice.


ABSTRACT: Renal ischemia-reperfusion injury causes acute renal failure, and the hallmarks of renal ischemia-reperfusion injury are inflammation, apoptosis, necrosis, and capillary dysfunction. Milk fat globule-epidermal growth factor-factor VIII (MFG-E8), a membrane-associated secretory glycoprotein, is produced by immune cells and reported to participate in multiple physiologic processes associated with tissue remodeling. We have recently shown that MFG-E8 treatment attenuates organ injury, inflammatory responses, and survival after sepsis through the enhancement of phagocytosis of apoptotic cells. The purpose of this study was to determine whether administration of MFG-E8 attenuates renal ischemia-reperfusion injury.Prospective, controlled, and randomized animal study.: A research institute laboratory.Male C57BL/6J mice (20-25 g).: Renal ischemia-reperfusion injury with bilateral renal pedicle clamping for 45 mins, followed by reperfusion. A recombinant murine MFG-E8 (0.4 ?g/20 g) was given intraperitoneally at the beginning of reperfusion.MFG-E8 levels, organ injury variables, inflammatory responses, histology, apoptosis, and capillary functions were assessed at 1.5 and 20 hrs after reperfusion. A 60-hr survival study was conducted in MFG-E8 and recombinant murine MFG-E8-treated wild-type mice. After renal ischemia-reperfusion injury, MFG-E8 mRNA and protein expressions were significantly decreased in the kidneys and spleen. Treatment with recombinant murine MFG-E8 recovered renal dysfunction, significantly suppressed inflammatory responses, apoptosis, necrosis, and improved capillary functions in the kidneys. In the survival study, MFG-E8 mice showed a significant deterioration and, in contrast, recombinant murine MFG-E8-treated wild-type mice showed a significant improvement of survival compared with vehicle-treated wild-type mice.MFG-E8 can be developed as novel treatment for renal ischemia-reperfusion injury. This protective effect appears to be mediated through the enhancement of apoptotic cell clearance and improvement of capillary functions in the kidneys.

SUBMITTER: Matsuda A 

PROVIDER: S-EPMC3158289 | BioStudies | 2011-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3401639 | BioStudies
2008-01-01 | S-EPMC2519188 | BioStudies
2007-01-01 | S-EPMC2075476 | BioStudies
2014-01-01 | S-EPMC4076467 | BioStudies
2011-01-01 | S-EPMC3217009 | BioStudies
1000-01-01 | S-EPMC5979943 | BioStudies
2017-01-01 | S-EPMC5467455 | BioStudies
2020-01-01 | S-EPMC7769466 | BioStudies
2020-01-01 | S-EPMC6959219 | BioStudies
2012-01-01 | S-EPMC3382007 | BioStudies